STXS News and Press, Stereotaxis Inc. From 11/09/23

ST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2023. “Stereotaxis continues to del...

2023-11-08 13:05:49 ET More on Stereotaxis Sizing Up Stereotaxis Stereotaxis director acquires further indirect stake Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis For further details see: Stereotaxis ...

ST. LOUIS, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the United States have been treated successfully utilizing Abbott’s EnSite...

ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 third quarter on Thursday, November 9, 2023 before the ...

ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation’s 7 th Annual Meeting, wh...

2023-09-19 14:03:28 ET More on Stereotaxis Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis Financial information for Stereotaxis Sizing Up Stereotaxis Stereotaxis, Inc. (STXS) Q2 2023 Earnings Call Transcrip...

ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the ...

2023-09-05 09:47:27 ET Summary Stereotaxis, Inc. is a medical device company that produces robotic systems for interventional procedures. While the stock is down sharply from its mid-2021 highs, the company has some important potential milestones on the medium-term horizon. Th...

ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Overland Park Regional Medical Center (OPRMC) launched and successfully completed the fi...

ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its technology will be the focus of multiple live long-distance telerobotic procedures at the upcoming...